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"'Consorzio Mario Negri Sud", Santa Maria Imbaro, Italy 
Objective: To assess the predictivity of predefined variables with respect o long-term mortality in a cohort of patients 
with chronic critical leg ischaemia (CLI). 
Design" Prospective observational study. 
Methods: Census offices were asked to release information on survival or death status of 574 patients with CLI 2 years 
after their recruitment in the study. 
Results: 0f522 patients with available information, 165 (31.6%) died within 2 years of hospitaI admission, mostly from 
vascular causes as expected. Among the variables considered, male sex, current smoking, arterial hypertension, diabetes 
metlitus, hypercholesterolaemia, obesity, history of myocardial infarction and low ankle systolic pressure showed no 
univariate association with mortality. The multivariate analysis also excluded revascularisation procedures and the 
Fontaine stage as prognostic factors in terms of mortality. Besides age >_ 70 years (relative risk, RR 1.94; 95% confidence 
interval (CI) 1.37-2.70), only a history of stroke (RR 1.82; 95% CI 1.19-2.79) and major amputation (RR 1.90; 95% 
CI 1.30-2.80) were significantly associated with mortality. 
Conclusions: CLI is a clinical condition of such severity that most of the recognised cardiovascular risk factors cannot 
further influence the fate of the patients, one-third of whom die within 2 years. 
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Introduction 
The prognosis of patients with critical leg ischaemia 
(CLI) in terms of life expectancy is notoriously poor .  ~'2 
Though possible predictors of mortality in these 
patients have been extensively investigated, 3-s it is still 
uncertain whether and to what extent a history of 
cardiovascular morbidity, arterial hypertension rdia- 
betes, the presence of trophic lesions, and any attempt 
at invasive revascularisation actually influence the fate 
of patients. 
We report he 2-year mortality data of a large cohort 
of patients enrolled in an epidemiological study, 9the 
aim of which was to describe the characteristics and 
clinical outcome of patients with CLI. Attention was 
paid to the potentially prognostic factors, with par- 
ticular regard to history of cardiovascular risk factors 
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and events, peripheral manifestations of the disease, 
and interventions undertaken. 
Methods 
Long-term mortality data of patients with CLI have 
been obtained through census offices in the frame of 
an epidemiological survey undertaken by a rep- 
resentative sample of vascular surgery and angiology 
departments of the Italian National Health Service. The 
study methodology and main results have previously 
been published. 9 The study includes patients uffering 
from leg ischaemia considered as chronic and critical 
according to clinical criteria (i.e. persistently recurring 
rest pain for at least 2 weeks and/or foot ulceration 
and gangrene). Ankle pressure values, recommended 
as definition criterion of CLI, 2 were collected to allow 
subsequent subgroup analyses, but were not con- 
sidered as inclusion criteria in the absence of literature 
agreement on its contribution to the definition of the 
d isease ,  3'1°'11 as  agreed by the clinical investigators 
involved in the study. 
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For all the 574 patients with CLI sequentially ad- 
mitted to each of the 69 participating centres over 3 
months, demographic data and anamnestic and clinical 
informations were collected, including: previous 
cardiovascular events, time of onset of peripheral dis- 
ease and presence of major cardiovascular risk factors; 
characteristics of the symptoms and signs qualifying 
the ischaemia as chronic and critical; diagnostic 
procedures; number, side(s) and level(s) of vascular 
obstruction(s); invasive procedures and/or pharmaco- 
logical treatments; major amputations and relevant 
clinical events including death. 
For each patient enrolled a follow-up visit was 
planned 3months after hospital discharge to document 
survival or report he date and cause of death, and to 
record major amputations, persistence and clinical 
characteristics of CLI and any invasive revascularisa- 
tion procedures undertaken following discharge from 
the index admission. 
Two years after the recruitment of the study popu- 
lation census offices were asked to certify the survival 
or death of each patient enrolled in the study and, in 
the case of death, its date and possible cause. Because 
the cause of death is often missing or unreliably re- 
ported in census forms, only diagnoses reporting basic 
(and concomitant) disease(s) and a recognised fatal 
event have been taken into consideration for the ana- 
lysis of the causes of death; the others are referred to 
as "uncertain/unknown". 
Mortality was also analysed with respect to relevant, 
prospectively selected, emographic and clinical char- 
acteristics of patients in order to define their predictive 
value. The selected variables were: old age ( > 70 years); 
gender (male); arterial hypertension (defined as sys- 
tolic blood pressure >160mmHg and/or diastolic 
blood pressure >95mmHg, or presence of anti- 
hypertensive treatment); diabetes (fasting serum gluc- 
ose levels >_ 7.8 mmol/1 (140mg/dl) or ongoing 
treatment with insulin or oral hypoglycaemic agents); 
hypercholesterolaemia (serum total cholesterol levels 
>_ 6.4 mmol/1 (250 mg/dl) or ongoing cholesterol-low- 
ering treatment); obesity (body mass index [(body 
weight in kg)/(height in m) 2] >__30); history of myo- 
cardial infarction or stroke; major amputation (at or 
above the ankle) and revascularisation procedures (by- 
pass, thromboendoarterectomy, percutaneous trans- 
luminal angioplasty) performed either before or 
during the index observation period. 
The association of each selected variable with mor- 
tality was assessed first by the Mantel-Haenszel test 
and expressed as an odds ratio (OR) and 95% con- 
fidence interval (CI). Relative risk values along with 
their 95% CI were used to represent the results of a 
Table 1. Baseline characteristics of the study population (522 
patients). Age: mean±s.D. 70.7±9.7; median 71.0. 
1~ (%) 
Sex (male) 394 (75.5) 
Previous cardiovascular morbidity 
Myocardial infarction 98 (18.8) 
Stroke 54 (10.3) 
Claudication i termittens 449 (86.0) 
Previous interventions 
Revascularisation procedures* 113 (21.6) 
Amputation 
Major 30 (5.8) 
Minor 22 (4.2) 
Risk factors 
Arterial hypertension 303 (58.0) 
Diabetes mellitus 157 (30.1) 
Hypercholesterolaemia 73 (14.0) 
Obesity 34 (6.5) 
Smoking 
Past 247 (47.5) 
Current 129 (24.8) 
Clinical picture at entry 
Fontaine's stage 
IIIB 200 (38.3) 
IV 322 (61.7) 
Ankle brachial pressure index 
>0.75 19 (6.2) 
0.51-0.75 33 (0.7) 
0.25-0.50 188 (61.2) 
<0.25 67 (21.8) 
In-hospital interventions/events 
Revascularisation procedures* 232 (44.4) 
Major amputation 49 (9.4) 
Myocardial infarction 6 (1.2) 
Stroke 8 (1.5) 
* Bypass, thromboendoarterectomy, percutaneous transluminal 
angioplasty. 
multivariate analysis, including all the selected vari- 
ables using the Cox regression model. The Student's 
t-test and the Mantel-Haenszel t st were used to assess 
the statistical significance of the differences between 
means and proportions. 
Results 
Study population 
Long-term survival data was obtained for 522 of the 
574 patients with CLI enrolled in the study. Table 1 
illustrates the basic characteristics of this population, 
mainly represented by elderly (median age 71.0 years) 
males (75.5%), with a high cardiovascular risk in terms 
of prevalence of risk factors (over half had arterial 
hypertension, one-third were diabetics, and one-quar- 
ter were current smokers) and of prior vascular mor- 
bidity (one-fifth ad suffered from acute myocardial 
infarction, 1/10 from stroke, 1/20 had undergone a 
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Table 2. Long-term mortality in a cohort of 574 patients with CLI. 
At 1 year At 2 years 
Censored (n) 552* 401f 
Dead (n) 121 44 
Causes 
Cardiovascular 44 13 
Non-vascular 8 6 
Unknown/uncertain 69 25 
Per year mortality (%) 21.9 11.0 
Causes 
Cardiovascular 36.4 29.5 
Non-vascular 6.6 13.6 
Unknown/uncertain 57.0 56.8 
Cumulative mortality (%) --  31.6 
Causes 
Cardiovascular 34.5 
Non-vascular 8.5 
Unknown/uncertain 57.0 
* No information was provided on 22 patients. 
~ No information was available on 30 patients still alive at 1 year. 
major amputation). Most patients (86.0%) had a pre- 
vious history of claudication; furthermore, in- 
terestingly enough, often of recent onset: 165 (31.6%) 
had suffered from claudication since the year pre- 
ceding the onset of CLI and 241 (46.2%) for the last 2 
years. In 73 (14%) patients there had been no prior 
symptoms. At the time of recruitment 44.4% under- 
went invasive procedures of revascularisation and 
9.4% primary major amputation; 2.7% suffered from 
myocardial infarction or stroke; about 5% died within 
1 month of admission. 
Information on 1-year survival was available for 552 
patients: 121 (21.9%) of them were dead. At 2 years 
information was available for 401 of the 431 survivors: 
a further 44 (11.0%) patients had died. Therefore, the 
overall 2-year mortality rate among the 522 patients 
with information was 31.6% (n = 165) (Table 2). Though 
affected by missing, uncertain and generic diagnoses, 
the reporting of causes of death in the census forms 
was considered reliable in 71 of the 165 cases (43.0%). 
As expected, the overall incidence of vascular deaths 
was much higher than that of non-vascular deaths 
(34.5 vs. 8.5%); being, however, relatively higher at 
the end of the first (36.4% vs. 6.6%) than over the 
second (29.5% vs. 13.6%) year of follow-up (Table 2). 
Univariate analysis 
Data from the univariate analysis of the predictivity 
of the selected variables are summarised in Table 3. 
Mortality was significantly higher among people over 
70 years of age (42.0% vs. 22.4%, respectively); among 
females (44.5%) than in males (29.2%); and among 
patients with trophic lesions (36.3%) as compared 
Table 3. Univariate predictors of 2-year mortality among a popu- 
lation of 522 patients with CLI. 
Variable n n Z 2 (2p) Odds 95% CI 
(patients) (deaths) ratio 
Age 
<70 241 54 22.48 1.00 
> 70 281 118 (<0.001) 2.42 1.68-3.49 
Sex 
Male 394 115 10.28 1.00 
Female 128 57 (<0.001) 2.00 1.31-3.06 
Stage 
III 200 55 4.36 1.00 
IV 322 117 (0.037) 1.49 1.02-2.17 
Ankle pressure 
>50 mmHg 139 44 0.78 1.00 
< 50 mmHg 170 46 (0.377) 0.80 0.48-1.35 
Hypertension 
No 219 66 1.35 1.00 
Yes 303 106 (0.245) 1.24 0.86-1.80 
Diabetes 
No 365 114 1.61 1.00 
Yes 157 58 (0.203) 1.29 0.87-1.93 
Hypercholesterolaemia 
No 449 153 1.84 1.00 
Yes 73 19 (0.175) 0.68 0.37-1.23 
Obesity 
No 488 161 0.006 1.00 
Yes 34 11 (0.939) 0.97 0.43-2.15 
Smoking 
No 391 138 4.84 1.00 
Yes 129 32 (0.027) 0.62 0.41-0.95 
History of IMA 
No 424 140 0.005 1.00 
Yes 98 32 (0.944) 0.98 0.62-1.57 
History of stroke 
No 468 145 7.91 1.00 
Yes 54 27 (0.005) 2.36 1.30-4.30 
Revascularisation 
No 234 88 4.15 1.00 
Yes 288 84 (0.042) 0.68 0.47-0.99 
Major amputation 
No 450 134 14.83 1.00 
Yes 72 38 (<0.001) 2.83 1.674.80 
with those with persistently recurring rest pain alone 
(27.5%). Mortality was also higher among non-smokers 
(35.3%) than among current smokers (24.8%). Hyper- 
tensive and normotensive patients had similar mor- 
tality rates (35.0% vs. 30.1%, respectively), as did 
patients with ankle pressure < or >50 mmHg (27.1% 
vs. 31.7%), diabetics and non-diabetics (36.9% vs. 
31.2%), patients with high and normal cholesterol 
levels (26.0% vs. 34.1%), obese or not (32.4% vs. 33.0%), 
and those with or without history of myocardial in- 
farction (32.7% vs. 33.0%). Mortality was significantly 
higher in patients with prior stroke (50.0%) as com- 
pared with those who had never suffered from this 
event (31.0%). Death was almost unavoidably as- 
sociated with myocardial infarctions, and strokes oc- 
curred during the observation period: all the six 
myocardial infarctions and six out of eight strokes 
were fatal. This was not an unexpected finding; for 
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Table 4. Independent predictors and factors not predictive of 2- 
year mortality in 522 patients with CLL 
Variable Relative risk 95% CI 
Not predictive 
Female sex 1.38 0.97-1.95 
Stage IV 1.08 0.77-1.52 
Low ankle pressure 0.81 0.54-1.24 
Hypertension 1.16 0.84-1.60 
Hypercholesterolaemia 0.85 0.52-1.39 
Obesity 0.85 0.45-1.60 
Diabetes 1.12 0.80-1.56 
Smoking 0.90 0.60-1.35 
History of AMI 0.92 0.61-1.37 
No revascularisation 1.17 0.86-1.60 
Predictive 
Age _> 70 1.93 1.37-2.70" 
History of stroke 1.82 1.19-2.79t 
Major amputation 1.90 1.30-2.805 
* 2p = 0.0001. 
$ 2p = 0.006. 
$ 2p = 0.001. 
this reason these events were not selected as possible 
predictors, but rather egarded as likely direct causes 
of death. 
Finally, mortality was higher among amputees than 
in non-amputees (52.8% vs. 29.8%) and among patients 
who did not undergo invasive revascularisation pro- 
cedures (37.6%) compared to patients exposed to sur- 
gery (29.2%). In contrast with the observations on 
myocardial infarction and stroke, mortality did not 
significantly differ between patients with a history of 
major amputation or of revascularisation procedures 
and patients undergoing such interventions during 
hospital stay: OR of prior and current amputations = 
1.25, 95% CI 0.51-3.09; OR of prior and current re- 
vascularisation procedures=0.80, 95% CI 0.49-1.32. 
For this analysis patients undergoing amputation or 
revascularisation procedures both before and during 
the observation period and those undergoing different 
reconstructive interventions or percutaneous trans- 
luminal angioplasty (PTA) are counted only once. 
Multivariate analysis 
The only factors independently associated with a 
higher mortality in the multiple logistic regression 
analysis (Table 4), besides advanced age, were a history 
of stroke and major amputation. When controlling for 
possible confounding variables, the statistical sig- 
nificant association with gender (2p = 0.070), Fontaine's 
stage IV (2p=0.189), revascularisation procedures 
(2p=0.318) and smoking (2p=0.611) disappeared. 
Moreover, even if considered as a continuous variable, 
ankle pressure did not show any association with 
mortality (OR 1.0, 95% CI 0.99-1.01). 
Discussion 
Besides being a marker of generalised arteriosclerosis, 
peripheral artery disease is regarded as a more power- 
ful predictor of any cause of mortality than ischaemic 
heart disease or carotid stenosis, n Notwithstanding 
the relatively high rate of patients lost to follow-up, 
the large cohort enrolled in this study supports this 
view. Besides confirming the high long-term ortality 
associated with this disease, this epidemiological sur- 
vey fails to show any association between variables 
usually deemed predictive of a poor prognosis and 
mortality. Male patients, current smokers, patier(ts 
suffering from arterial hypertension, diabetes, or even 
from a prior myocardial infarction do not appear to 
be at a higher isk of death. The most likely explanation 
is that the clinical condition of these patients in the 
terminal stage of the disease is so critical as to be 
unaffected by risk factors, concomitant diseases and 
events usually recognised as determinants of un- 
favourable outcome. Men and smokers, in fact, ex- 
perience a lower risk of death. With respect to gender, 
this finding may be explained by the lower risk for 
men of dying from coronary events than women (at 
least in the short term)J 3 On the other hand, earlier 
smoking-related vascular and non-vascular deaths 
might have operated a selection of subjects less prone 
to smoking-related mortality, or the lower mortality 
observed among smokers may reflect a "healthier 
smoker" effect. 
The presence of trophic lesions (foot ulceration or 
gangrene) does not appear to be a risk marker com- 
pared to patients uffering from rest pain only. Though 
possibly affecting the prognosis in terms of leg salvage, 
the stage of the peripheral disease does not seem to 
threaten patients' survival. Revascularisation pro- 
cedures appear to behave in a similar way. This finding 
conflicts with other observations on the reduction of 
mortality associated with arterial reconstruction. 3 This 
may be due to the fact that our analysis includes 
interventions performed during the index hos- 
pitalisation period as well as those undertaken before. 
The higher risk associated with a persistent CLI con- 
dition despite previous revascularisation may have 
worsened the prognosis of the overall population 
undergoing interventions, thus masking the positive 
prognostic value of the procedure undertaken at the 
time of recruitment. However, it is not surprising that 
an improved peripheral circulation ca~mot prolong 
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survival even though saving the legs. Indeed, in ac- 
cordance with the results of this survey a recent report  
of the Swedvasc registry 14 shows that a l though an 
increasing proport ion of patients with CLI benefit f rom 
invasive revascularisation procedures,  1 year after re- 
cruitment this concerns only "l iving patients with 
intact legs", mortal i ty as such being reduced only in 
the short term. 
Besides advanced age, which obviously influences 
survival,  only previous strokes and major amputat ions  
independent ly  predict mortal i ty in CLI. A history 
of stroke has been shown to significantly increase 
mortal i ty also in the long term, 1~ unlike myocardia l  
infarction, 16 which does not appear  to entail a higher 
mortal i ty in patients with CLI. Moreover,  the fear of 
haemorrhagic  complications associated with anti- 
thrombotic treatment may induce clinicians to adopt  
less intensive secondary prevent ion strategies, par- 
ticularly in the case of cerebrovascular, rather than of 
coronary, events. Such a pol icy may imply  a lower 
protect ion of patients with pr ior stroke as compared 
with people with history of myocardia l  infarction. It 
is not surpris ing that major amputat ion  should be 
associated with an increase in the risk of death, as 
already observed in several studies. 3'7"s Such an as- 
sociation could account for the loss of predict ive value 
of both stage and revascularisation procedures in the 
mult ivariate analysis. However ,  this does not appear  
to be the case, because when amputat ion  is excluded 
f rom the Cox regression analysis, revascularisation 
procedures do not appear to significantly contribute 
to the model  (data not shown). 
In conclusion, whi le better selection of patients and 
techniques may al low revascularisation procedures to 
improve leg salvage, it may  not have much effect on 
the survival  of patients with CLI. Due to the lack of 
predictors of mortality, clinical trials of phar-  
macological  interventions in this area should not be 
restricted to part icular subgroups elected on the basis 
of clinical characteristics usual ly regarded as prog-  
nostic variables. 
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